STEP 2, run in participants with diabetes, is listed at 9.6 percent versus 1.7 percent, and STEP 3, which paired the medication with lifestyle intervention, at 15.3 percent versus 6.2 percent for lifestyle alone
After glucuronidation and sulfation, the metabolites are excreted in the urine (65%) and bile (35%)
Hernandez NS, Weir VR, Ragnini K, Merkel R, Zhang Y, Mace K, et al
For most patients, GLP-1 agonists represent safe and effective treatment options
Comparing Cagrilintide to Other Weight Management Therapies While several therapies exist for the treatment of obesity, cagrilintide stands out due to its unique dual receptor agonism
Functional medicine attempts to identify the factors that can be evaluated or modified and use them to create an individualized plan